GLP-1 agonists have clear cardiovascular benefits
Prostaglandins, 21, 89-96
Oral options might increase their willingness to initiate and adhere to treatment, potentially broadening the pool of people who can benefit from [GLP-1] therapy. Maintenance therapy after weight loss For people whove already lost weight with an injectable GLP-1, switching to a pill may help maintain progress without continuing injections
A broad spectrum of interventions for ME/CFS has been investigated, encompassing pharmacological options such as rituximab, rapamycin, and lumbrokinase, as well as non-pharmacological approaches including yoga, CBT, and acupuncture
How do we decide which members will be covered
As 2026 approaches, many people in Tampa are rethinking how they want to approach weight loss